Urine Aquaporin-2 Level is a Novel Marker for the Better Prognosis After Long-Term Tolvaptan Treatment in Patients With Advanced Heart Failure

被引：0
|
作者：
Imamura, Teruhiko
Kinugawa, Koichiro
Fujino, Takeo
Inaba, Toshiro
Maki, Hisataka
Hatano, Maasaru
Yao, Atsushi
Komuro, Issei
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Diuretics; Kidney; Vasopressins;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
9411
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Increased Urine Aquaporin-2 Relative to Plasma Arginine Vasopressin Is a Novel Marker of Response to Tolvaptan in Patients With Decompensated Heart Failure
    Imamura, Teruhiko
    Kinugawa, Koichiro
    Fujino, Takeo
    Inaba, Toshiro
    Maki, Hisataka
    Hatano, Masaru
    Yao, Atsushi
    Komuro, Issei
    CIRCULATION JOURNAL, 2014, 78 (09) : 2240 - U441
  • [2] Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart Failure
    Imamura, Teruhiko
    Kinugawa, Koichiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (01)
  • [3] Increased Urine Aquaporin-2 Levels Relative to Plasma Arginine Vasopressin is a Novel Marker of Response to Tolvaptan
    Imamura, Teruhiko
    Kinugawa, Koichiro
    Fujino, Takeo
    Inaba, Toshiro
    Maki, Hisataka
    Hatano, Masaru
    Yao, Atsushi
    Komuro, Issei
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S174 - S174
  • [4] Long-term Effects of Tolvaptan in Patients with Heart Failure
    Ogawa, Hayato
    Ajioka, Masayoshi
    Otaka, Naoya
    Sakaguchi, Teruhiro
    Nakano, Yoshihisa
    Hara, Akitoshi
    Murase, Yosuke
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S180 - S180
  • [5] LONG-TERM RENOPROTECTIVE EFFECTS OF TOLVAPTAN IN PATIENTS WITH ACUTE HEART FAILURE
    Oka, Tatsufumi
    Hamano, Takayuki
    Ohtani, Tomohito
    Sakaguchi, Yusuke
    Matsui, Isao
    Yamaguchi, Osamu
    Sakata, Yasushi
    Isaka, Yoshitaka
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [6] Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial
    Suzuki, Satoshi
    Yoshihisa, Akiomi
    Yamaki, Takayoshi
    Sugimoto, Koichi
    Kunii, Hiroyuki
    Nakazato, Kazuhiko
    Abe, Yukihiko
    Saito, Tomiyoshi
    Ohwada, Takayuki
    Suzuki, Hitoshi
    Saitoh, Shu-ichi
    Kubota, Isao
    Takeishi, Yasuchika
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [7] Factors associated with readmission after long-term administration of tolvaptan in patients with congestive heart failure
    Yamashita, Shoko
    Takenaka, Miki
    Ohbayashi, Masayuki
    Kohyama, Noriko
    Kurihara, Tatsuya
    Sunaga, Tomiko
    Ishiguro, Hisaaki
    Kogo, Mari
    SINGAPORE MEDICAL JOURNAL, 2024, 65 (11) : 614 - 623
  • [8] Effect of tolvaptan on long-term prognosis in Japanese patients with heart failure: a systematic review and meta-analysis
    Nakao, Y.
    Saito, M.
    Yamaguchi, O.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1027 - 1027
  • [9] Long-term effects of tolvaptan in patients requiring recurrent hospitalization for heart failure
    Ogawa, Hayato
    Ajioka, Masayoshi
    Ishii, Hideki
    Okumura, Takahiro
    Murase, Yosuke
    Osanai, Hiroyuki
    Nakasima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    Murohara, Toyoaki
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2015, 77 (03): : 355 - 362
  • [10] Prognostic factors for long-term outcomes in acute decompensated heart failure patients under tolvaptan treatment
    Matsumura, Koichiro
    Morishita, Shun
    Taniguchi, Naoki
    Takehana, Kazuya
    Takahashi, Hiroki
    Otagaki, Munemitsu
    Yoshioka, Kei
    Yamamoto, Yoshihiro
    Takagi, Masahiko
    Shiojima, Ichiro
    HEART AND VESSELS, 2019, 34 (04) : 607 - 615
12345